In a simulated cohort of patients with subclinical device-detected atrial fibrillation (AF), broad use of direct oral ...

More quality-adjusted life-years with gene therapy, but at a much higher cost ...

Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a key test in primary care to inform which people with ...

The phase III NOTABLE trial has revealed that nimotuzumab plus gemcitabine achieves greater clinical benefit in the first-line treating K-Ras wild type locally advanced (LA) or metastatic pancreatic ...

Chronic kidney disease (CKD) in type 2 diabetes (T2D) patients is associated with end-stage renal disease and significant economic burden. While sodium glucose cotransporter-2 inhibitors (SGLT2i) show ...

As an epidemiologist and physician, I’ve long been concerned about how health interventions for marginalized communities are evaluated. A new study explores that concern and offers some solutions for ...

The study in US veterans found that oral nicotinamide was “a cost-effective and patient-centric preventive approach” for keratinocyte carcinoma (KC), the study authors reported.

This study examines the availability of cost-effectiveness analyses for medical devices, both in terms of the number of studies and when studies are published. Objectives: Academic researchers and ...

Integrating behavioral health into primary care is cost-effective from the US health system perspective, with reduced prescription drug expenses being a key driver of these savings. Objective: To ...

To address the gap between opportunity costs and cost-effectiveness thresholds, we must identify the marginal cost of a unit of health for health care systems. Amid efforts to reduce spending on ...

Vaccines for respiratory syncytial virus (RSV) can reduce hospitalization and costs for older adults, and vaccination programs focused on patients with underlying medical conditions appear to be the ...